Xellia Pharmaceuticals Overview

Life ScienceCompany

Is Xellia Pharmaceuticals PE-backed?

Yes. Xellia Pharmaceuticals is owned by private equity investor Novo Holdings A/S.

Was Xellia Pharmaceuticals formerly PE-backed?

Yes. Xellia Pharmaceuticals was formerly owned by 1 private investor.

Where is Xellia Pharmaceuticals headquartered?

Xellia Pharmaceuticals is headquartered in Copenhagen, Denmark.

What sector is Xellia Pharmaceuticals in?

Xellia Pharmaceuticals is a life science company.

When was Xellia Pharmaceuticals founded?

Xellia Pharmaceuticals was founded in 1994.

Xellia Pharmaceuticals

Xellia Pharmaceuticals AS

Dalslandsgade 11,
Copenhagen, 2300
Denmark,
+45 32-64-55-00
www.xellia.com

Xellia Pharmaceuticals is a provider and developer of anti-infective drugs, active pharmaceutical ingredients (API), and final dosage presentation. Its clients include a range of national, multinational, and global pharmaceutical and generic companies. Xellia Pharmaceuticals was formed in 1994 and is based in Copenhagen, Denmark.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Xellia Pharmaceuticals

Life Science Companies , Denmark Companies